NR3C2 and Hypertension: Arterial hypertension was prevalent at baseline (Table 1) and untreated in two cases; most patients received combined antihypertensive treatments with mineralocorticoid receptor antagonists being the most commonly used drugs (n = 5), although in some cases, their main indication was to reduce androgenic symptoms, followed by calcium channel blockers and angiotensin-converting enzyme inhibitors (n = 4 each).